Delivery Order SPE2DB22D3401-SPE2DB25FT5ZQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,888.42 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive transdermal patch. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,163.04 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) under a firm fixed price contract type. This non-set-aside award was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches on September 5, 2025, with a ceiling value of $3,164.04 under a firm fixed-price contract type. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,965.60 delivery order on August 29, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and performance to be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,097.58 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (three-unit supply) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5ZQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,312.08 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity 3). This firm fixed price, competitively awarded delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in military and veteran healthcare procurement. The company maintains an extensive portfolio of federal medical supply contracts with DLA and serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard. As a competitive awardee with no set-aside designation, AmerisourceBergen continues to demonstrate capability in fulfilling diverse federal pharmaceutical procurement requirements across multiple therapeutic domains through its flexible contracting arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/4/25 |